Odulimomab (anti-LFA1), an anti-LFA-1 monoclonal antibody, inhibits T lymphocyte proliferation and provides protection against ischemia and reperfusion injury. It is utilized in researching transplant rejection and immunological diseases [1] [2].
CAS Number:
[159445-64-4]
* VAT and and shipping costs not included. Errors and price changes excepted
